Nationwide Fund Advisors’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-91,474
Closed -$1.56M 123
2017
Q3
$1.56M Hold
91,474
0.01% 1557
2017
Q2
$1.48M Sell
91,474
-20,854
-19% -$330K 0.01% 1565
2017
Q1
$1.95M Sell
112,328
-2,058
-2% -$34.4K 0.01% 1410
2016
Q4
$1.93M Sell
114,386
-2,711
-2% -$45.2K 0.01% 1421
2016
Q3
$2.05M Hold
117,097
0.01% 1377
2016
Q2
$1.68M Buy
117,097
+430
+0.4% +$5.37K 0.01% 1449
2016
Q1
$1.43M Buy
116,667
+28,293
+32% +$313K 0.01% 1512
2015
Q4
$1.07M Buy
88,374
+63,332
+253% +$780K ﹤0.01% 1704
2015
Q3
$330K Hold
25,042
﹤0.01% 2328
2015
Q2
$411K Sell
25,042
-1,316
-5% -$21.8K ﹤0.01% 2355
2015
Q1
$469K Sell
26,358
-543
-2% -$10.1K ﹤0.01% 2265
2014
Q4
$511K Sell
26,901
-12,691
-32% -$215K ﹤0.01% 2177
2014
Q3
$543K Buy
39,592
+45
+0.1% +$642 ﹤0.01% 2164
2014
Q2
$646K Buy
39,547
+155
+0.4% +$2.24K ﹤0.01% 2115
2014
Q1
$620K Buy
39,392
+1,427
+4% +$23.3K ﹤0.01% 1961
2013
Q4
$653K Buy
37,965
+11,810
+45% +$182K ﹤0.01% 2114
2013
Q3
$345K Buy
26,155
+4,198
+19% +$49.5K ﹤0.01% 2399
2013
Q2
$248K Buy
+21,957
New +$234K ﹤0.01% 2388

Other funds holding ANGO

Nationwide Fund Advisors's ANGO Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of AngioDynamics (ANGO) in Q4 2017, closing a stake of 91,474 shares — an estimated $1.56M sold.

Nationwide Fund Advisors first reported a position in ANGO in Q2 2013 and held it in 18 quarters. The position peaked at $2.05M in Q3 2016. 169 funds tracked by Wall St. Rank hold ANGO as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining AngioDynamics position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 91,474 AngioDynamics shares in Q4 2017, an estimated $1.56M.
  • Nationwide Fund Advisors first reported a position in AngioDynamics in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's AngioDynamics position peaked at $2.05M in Q3 2016.
  • 169 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.